Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-22

FDA Approved: LOPERAMIDE HCL AND SIMETHICONE — Supplemental Application (Ohm Laboratories Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Loperamide HCl and Simethicone from Ohm Laboratories Inc., updating labeling for the combination product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOPERAMIDE HCL AND SIMETHICONE (loperamide hydrochloride and simethicone)

Snippet

SUPPL AP for LOPERAMIDE HCL AND SIMETHICONE (LOPERAMIDE HCL AND SIMETHICONE)